Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-21 06:03 am Purchase | 2022-10-18 | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 9,376,402 19.900% | 5,071,955 (+117.83%) | Filing History |
| 2022-10-19 4:37 pm Purchase | 2022-10-17 | 13D | DICE THERAPEUTICS INC DICE | RA CAPITAL MANAGEMENT L.P. | 6,848,911 14.400% | 1,640,000 (+31.48%) | Filing History |
| 2022-10-17 5:21 pm Purchase | 2022-10-07 | 13G | INHIBRX INC INBX | RA CAPITAL MANAGEMENT L.P. | 3,185,831 8.160% | 3,185,831 (New Position) | Filing History |
| 2022-10-17 4:31 pm Purchase | 2022-10-05 | 13G | ADICET BIO INC ACET | RA CAPITAL MANAGEMENT L.P. | 147,772 5.500% | 147,772 (New Position) | Filing History |
| 2022-10-14 4:03 pm Sale | 2022-10-14 | 13D | FORMA THERAPEUTICS HLDGS INC FMTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,040,309 (Position Closed) | Filing History |
| 2022-10-13 4:30 pm Purchase | 2022-10-03 | 13G | DESIGN THERAPEUTICS INC DSGN | RA CAPITAL MANAGEMENT L.P. | 2,971,231 5.320% | 2,971,231 (New Position) | Filing History |
| 2022-10-04 5:14 pm Unchanged | 2022-09-29 | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 829,858 11.010% | 0 (Unchanged) | Filing History |
| 2022-10-03 4:30 pm Purchase | 2022-09-21 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | RA CAPITAL MANAGEMENT L.P. | 4,356,632 9.910% | 4,356,632 (New Position) | Filing History |
| 2022-09-27 10:40 am Unchanged | 2022-09-15 | 13G | MAGENTA THERAPEUTICS INC MGTA | RA CAPITAL MANAGEMENT L.P. | 3,588,081 6.090% | 0 (Unchanged) | Filing History |
| 2022-09-26 5:29 pm Sale | 2022-09-26 | 13D | POINT BIOPHARMA GLOBAL INC PNT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,003,018 (Position Closed) | Filing History |
| 2022-09-26 4:37 pm Sale | 2022-09-15 | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 3,588,081 6.090% | -24,126 (-0.67%) | Filing History |
| 2022-09-26 4:29 pm Purchase | 2022-09-15 | 13G | TF FINANCIAL CORP THRD | RA CAPITAL MANAGEMENT L.P. | 3,475,687 8.620% | 3,475,687 (New Position) | Filing History |
| 2022-09-16 4:29 pm Unchanged | 2022-09-14 | 13D | POINT BIOPHARMA GLOBAL INC PNT | RA CAPITAL MANAGEMENT L.P. | 9,003,018 8.650% | 0 (Unchanged) | Filing History |
| 2022-09-06 4:50 pm Purchase | 2022-09-02 | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 829,858 11.010% | 5,333 (+0.65%) | Filing History |
| 2022-09-06 4:30 pm Purchase | 2022-08-24 | 13G | COGENT BIOSCIENCES INC COGT | RA CAPITAL MANAGEMENT L.P. | 3,612,207 5.490% | 3,612,207 (New Position) | Filing History |
| 2022-09-02 4:30 pm Purchase | 2022-08-31 | 13D | FORMA THERAPEUTICS HLDGS INC FMTX | RA CAPITAL MANAGEMENT L.P. | 9,040,309 18.880% | 11,125 (+0.12%) | Filing History |
| 2022-08-29 5:01 pm Purchase | 2022-08-25 | 13D | POINT BIOPHARMA GLOBAL INC PNT | RA CAPITAL MANAGEMENT L.P. | 9,003,018 9.900% | 147,000 (+1.66%) | Filing History |
| 2022-08-26 4:38 pm Purchase | 2022-08-16 | 13G | FULCRUM THERAPEUTICS INC FULC | RA CAPITAL MANAGEMENT L.P. | 7,000,000 13.450% | 7,000,000 (New Position) | Filing History |
| 2022-08-15 5:19 pm Sale | 2022-08-15 | 13G | SCPHARMACEUTICALS INC SCPH | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,691,770 (Position Closed) | Filing History |
| 2022-08-15 5:15 pm Sale | 2022-08-15 | 13G | MACROGENICS INC MGNX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -6,103,594 (Position Closed) | Filing History |